University of California San Francisco
<p>Each of the deans of graduate education for the 10 UC campuses sent two students who have recently completed work on their doctoral degrees to the state capitol, where lawmakers are embroiled in painful decision-making to address state budget shortfalls.</p>
<p>UCSF, in partnership with the San Francisco Board of Supervisors and the Chinatown Public Health Clinic, offered free skin cancer screenings in Chinatown to mark National Skin Cancer Awareness Month.</p>
<p>Rates of deadly skin cancers are climbing among girls and young women. Researchers discover that the increase may be linked to sun exposure among the well-off.</p>
<p>UCSF has produced a series of video public service announcements (PSAs) that offer faculty expertise in coping with mental stress and other health-related issues in the aftermath of the Tohoku earthquake and tsunami on March 11 and continuing crises at the Fukushima Daiichi Nuclear Power Plant in Japan.</p>
The ongoing controversy surrounding the safety of using TASER® electrical stun guns took a new turn today when a team of cardiologists at the University of California, San Francisco announced findings suggesting that much of the current TASER®-related safety research may be biased due to ties to the devices’ manufacturer, TASER International, Inc.
The UCSF Department of Dermatology, in partnership with the San Francisco Board of Supervisors and the Chinatown Public Health Clinic, will offer free skin cancer screenings in Chinatown to mark National Skin Cancer Awareness Month.
Three UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their investigations of treatment strategies for degenerative muscle diseases, such as muscular dystrophy, and heart disease, and to determine why human embryonic stem cells are susceptible to forming tumors.
<p>Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.</p>
<p>UCSF's basic research over nearly two decades has led to the first novel antitoxin to treat botulism in nearly a century – becoming the first recombinant human therapy to target one of the most dangerous substances known to man and offering a new defense against bioterrorism.</p>
May 2011
<p>Blending state-of-the art technology and cutting-edge design, UCSF’s new cardiovascular research building at Mission Bay integrates basic and clinical research to address important questions in cardiovascular biology and disease. </p>